Skip to main content
. 2016 Dec 15;34(2):300–323. doi: 10.1007/s12325-016-0462-y

Fig. 2.

Fig. 2

Change in lipid parameters in patients with high and very high triglycerides with prescription omega-3 fatty acid preparations. a OM3EE [64, 65]; b IPE [63]; c OM3CA [66]; Apo B apolipoprotein B, IPE icosapent ethyl, non-HDL-C non-high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, OM3CA omega-3 carboxylic acids, NR not reported, OM3EE omega-3 fatty acid ethyl esters, TG triglycerides, VLDL-C very low-density lipoprotein cholesterol. Information not provided for the effect of OM3EE on apo B. Results are from different studies, as reported in the respective prescribing information, and cannot be directly compared